** Brokerage BMO CAPITAL MARKETS refers to the inclusion of Vertex. 
VRTX Two insurance companies unitedhealth ‘ 
Unh The approved drug list is a humble headwind.
** Tier 3 Designation is booked as a “non -elected” brand drug with low options.
** The drug, Journavx, is more expensive than the first or second stage drugs, and in general, there will be two more drugs, including low -cost generics or preferred drugs for patents.
** Drugs truly differentiated with tier 3 designation as Gilead ‘s 
Guild Livdelzi and Roche’s 
as VABYSMO still sees a powerful absorption -BMO
** Since VRTX seems to be provided as a differentiated alternative, this name will cause some patient access headwinds.
** 20 out of 333 brokers evaluates stock “purchase” or more, 12 “hold” and one “sales” or more. Their middle PT is $ 520
** VRTX fell 4.2% in 2024
